Based on published guidelines individuals with PTEN-hamartoma Tumor syndrome should undergo breast cancer surveillance similar to BRCA 1/2, colonoscopy surveillance every 5 years, biennial thyroid US, renal US every 1–2 years. Here, PTEN is linked to breast cancer.